STAT5A and cancer: The discussed work and mechanism of STAT5 O-GlcNAcylation raises the possibility of developing new anti-cancer therapy strategies by inhibiting O-GlcNAcylation of hyperactive STAT5 in combination with inhibition of hyperactive tyrosine kinase signaling.